Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy

Mol Ther. 2021 Jun 2;29(6):1946-1957. doi: 10.1016/j.ymthe.2021.04.020. Epub 2021 Apr 23.

Abstract

Extracellular vesicles (EVs) are bilayer membrane vesicles and act as key messengers in intercellular communication. EVs can be secreted by both neurons and glial cells in the central nervous system (CNS). Under physiological conditions, EVs contribute to CNS homeostasis by facilitating omnidirectional communication among CNS cell populations. In response to CNS injury, EVs mediate neuroinflammatory responses and regulate tissue damage and repair, thereby influencing the pathogenesis, development, and/or recovery of neuroinflammatory diseases, including CNS autoimmune diseases, neurodegenerative diseases, stroke, CNS traumatic injury, and CNS infectious diseases. The unique ability of EVs to pass through the blood-brain barrier further confers them an important role in the bidirectional communication between the CNS and periphery, and application of EVs enables the diagnosis, prognosis, and therapy of neuroinflammatory diseases in a minimally invasive manner.

Keywords: CNS diseases; diagnosis; extracellular vesicles; neuroinflammation; therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmunity
  • Biomarkers
  • Disease Management
  • Disease Susceptibility
  • Extracellular Vesicles / metabolism*
  • Host-Pathogen Interactions
  • Humans
  • Neuroinflammatory Diseases / diagnosis*
  • Neuroinflammatory Diseases / etiology*
  • Neuroinflammatory Diseases / therapy*

Substances

  • Biomarkers